Acute effects of oral pyridostigmine on memory and cognitive function in SDAT
- 17 March 1989
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 10 (2) , 199-204
- https://doi.org/10.1016/0197-4580(89)90031-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Measuring improvement in patients with dementiaGeriatric Nursing, 1986
- Efficacy of oral physostigmine in primary degenerative dementiaPsychopharmacology, 1985
- Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's DiseaseJournal of Neurochemistry, 1983
- Enhancement of memory processes in Alzheimer's disease with multiple- dose intravenous physostigmineAmerican Journal of Psychiatry, 1982
- Oral Administration of Chronic Physostigmine does not Improve Cognitive or Mnesic Performances in Alzheimer's Presenile DementiaInternational Journal of Neuroscience, 1982
- Physostigmine and its effect on six patients with dementiaAmerican Journal of Psychiatry, 1981
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979
- The pharmacokinetics of pyridostigmineNeurology, 1976
- An analysis of the learning deficit following hyoscine administration to manBritish Journal of Pharmacology, 1973